|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 98.60 SAR | +0.15% |
|
-2.86% | +3.79% |
| 05-14 | Riyad Capital Downgrades Nahdi Medical to Neutral, Trims PT | MT |
| 05-14 | Riyad Capital Revises Rating, Price Target on Nahdi Medical After Q1 Earnings | MT |
EPS & Dividend: Nahdi Medical Company
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | 5.5 | 5.5 | 5.6 | 5.786 | 6.06 | 6.317 |
| Rate of return | - | 4.01% | 4.68% | 5.89% | 5.87% | 6.15% | 6.41% |
| EPS 2 | 6.83 | 6.87 | 6.31 | 6.39 | 6.497 | 7.158 | 7.785 |
| Distribution rate | - | 80.1% | 87.2% | 87.6% | 89.1% | 84.7% | 81.1% |
| Reference price 2 | 167.20 | 137.00 | 117.60 | 95.00 | 98.60 | 98.60 | 98.60 |
| Nbr of stocks (in thousands) | 130,000 | 130,000 | 130,000 | 130,000 | 130,000 | - | - |
| Announcement Date | 20/03/23 | 17/03/24 | 10/03/25 | 09/03/26 | - | - | - |
1SAR in Million2SAR
Estimates
Past dividends: Nahdi Medical Company
| 30/03/2026 | Ex-dividend date - 3 SAR | 05:00 |
| 13/08/2025 | Ex-dividend date - 2.6 SAR | 05:00 |
Upcoming Events: Nahdi Medical Company
| 19/05/2026 | Annual General Meeting | 16:30 | |
| 19/05/2026 | Extraordinary General Meeting | 17:30 |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 5.87% | 6.15% | 15.18x | 4.53x | 1.28x | |
| -.--% | -.--% | 21.22x | 1.87x | 0.94x | |
| -.--% | -.--% | 26.37x | 3.21x | 1.38x | |
| 2.11% | 2.36% | 16.09x | 1.68x | 0.71x | |
| 2.93% | 3.18% | 14.55x | 2.19x | 0.94x | |
| 3.78% | 4.2% | 17.12x | 7.73x | 1.05x | |
| 4.71% | 4.9% | 14.43x | 2.7x | 0.6x | |
| - | - | - | - | 0.28x | |
| - | - | 35.72x | - | - | |
| 1.55% | 1.83% | 25.91x | 4.93x | 0.81x | |
| Average | 2.62% | 2.83% | 20.73x | 3.60x | 0.89x | |
| Weighted average by Cap. | 1.53% | 1.65% | 20.72x | 2.89x | 0.96x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition